Search results
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Morningstar· 5 days agoCAMBRIDGE, MA / ACCESSWIRE / June 13, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 & ...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 4 days agoBoth experts caution that, anytime you’re spending time in crowded places, there’s still some risk...
A new Alzheimer's drug, combined COVID and flu vaccine update, and salmonella concerns. 3 health...
Yahoo Life Style via AOL· 3 days agoWhile this double shot won’t do anything to combat vaccine hesitancy, it’s...For example, an FDA...
Gateway - Quartz
Quartz· 4 hours agoQuartz is a guide to the new global economy for people who are excited by change. We cover business, finance, economics, technology, lifestyle, and leadership.
InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs
Forbes· 6 days agoAround 25 million Americans are affected by the eye disease Demodex blepharitis, which is caused by...
FDA: Shellfish from Oregon, Washington may have paralytic toxin
UPI· 7 days agoIn an advisory, the FDA told consumers to avoid oysters and bay clams harvested from Netarts and...
Surgeons use glowing dye to help identify, remove prostate cancer
UPI· 7 days agoA fluorescent dye in the early stages of development is giving doctors a "second pair of eyes"...